Recent Updates
Recently added Catalysts
BMY Positive Sentiment

Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025

Key Takeaway: Bristol Myers Squibb has announced its financial results for the fourth quarter and full year of 2025. The company will host a conference call for analysts and investors to discuss these results in detail. The call is scheduled for February 5, 2026, and will be accessible via a live audio webcast.
Price reaction · baseline $57.62 (2026-02-04 close) · hit pre-market · clean, no other BMY news in the window
day 0 close · peak
+3.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Bristol Myers Squibb reported strong financial results for 2025.
  • The company is committed to innovative medicine and patient care.
  • A conference call will provide further insights to investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+20%
120-day peak, hindsight
Typical move
1.7%
average across 15 past catalysts
Lead asset
Muraglitazar
Phase 3 · Type 2 Diabetes

Full Press Release Details

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today reported fourth quarter and full-year 2025 financial results.
Visit the company’s Investor Relations website athttp://investor.bms.comto view the detailed fourth quarter and full-year 2025earnings press releaseand investor presentation.
The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, February 5, 2026, which is accessiblehere. Company executives will review financial results with the investment community during the call.
A replay of the webcast will be available athttp://investor.bms.comapproximately three hours after the conference call concludes.
About Bristol Myers Squibb: Transforming Patients' Lives Through ScienceAt Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us atBMS.comand follow us onLinkedIn,X,YouTube,FacebookandInstagram.
corporatefinancial-news

Frequently Asked Questions

What financial results did Bristol Myers Squibb report?

Bristol Myers Squibb reported its fourth quarter and full-year financial results for 2025.

When is the conference call for investors?

The conference call for investors is scheduled for February 5, 2026, at 8:00 a.m. ET.

Where can I find the earnings press release?

The detailed earnings press release can be found on Bristol Myers Squibb's Investor Relations website.

How can I access the conference call?

The conference call will be accessible via a live audio webcast on the company's website.

Last updated: Feb 5, 2026